Gazyva (obinutuzumab)

**Product type:** Human Prescription Drug

**Active ingredient:** OBINUTUZUMAB

**Strength:** 1000 mg/40mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA125486)

**Pharmacologic class:** CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]